TRPV2 and non-small cell lung carcinoma: High expression of TRPV2 in drug-resistant cancers such as triple-negative breast or advanced non-small cell lung cancers is correlated with better prognosis, and the activation of TRPV2 by CBD assists drug (doxorubicin)-induced apoptosis in breast cancer cells or provokes apoptosis by CBD itself in lung cancer cells [55,56].